Medicaid Services Investment and Accountability Act of 2019

EMPOWER Care Act, S. 548/HR 1342. HR 6042/S. 2897, Issues pertaining to Medicaid Electronic Visit Verification rules, Direct Support Professional standard occupational category; Direct Support Professional visas. Medicaid Services Investment and Accountability Act of 2019, HR 1839. FY2020 Further Consolidated Appropriations Act (LHHSED, AG, Energy Water, Interior, Leg. Branch, MCVA, State-For. Ops, T-HUD), H.R. 1865.Isaiah Baker and Margie Harris-Austin Act, HR 5443. CARES Act, HR 748. Families First Coronavirus Response Act, HR 6201. Ensuring Access to Direct Support Professionals Act, S. 3220. Recognizing the Role of Direct Support Professionals Act, S. 3369. The Heroes Act, HR 6800. Continuing Appropriations Act, 2021 and Other Extensions Act, HR 8337. American Workers, Families, and Employers Assistance Act, S. 4318. Consolidated Appropriations Act, 2021, H.R. 133.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE

Excellence in Mental Health and Addiction Expansion Act, HR 1767/S. 824. Medicaid Services Investment and Accountability Act of 2019, HR 1839. Mental Health Access Improvement Act, HR 945/S. 286. National De-Escalation of Violence and Community Safety Training Act of 2019, HR 2457. Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020, HR 2740. A bill to provide for a 2-week extension of the Medicaid community mental health services demonstration program, and for other purposes, S. 2047. Sustaining Excellence in Medicaid Act of 2019, HR 3253. Continuing Appropriations Act, 2020, and Health Extenders Act of 2019, HR 4378. Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019, H.R.3055. FY2020 Further Consolidated Appropriations Act (LHHSED, AG, Energy Water, Interior, Leg. Branch, MCVA, State-For. Ops, T-HUD), H.R. 1865. Prescription Drug Pricing Reduction Act of 2019, S. 2543. CARES Act, HR 748. Families First Coronavirus Response Act, HR 6201.The Heroes Act, HR 6800. Continuing Appropriations Act, 2021 and Other Extensions Act, HR 8337. American Workers, Families, and Employers Assistance Act, S. 4318. Consolidated Appropriations Act, 2021, H.R. 133.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR1839; S.237/HR808; S.317/H.R.1226; S.433; HR748; HR133

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1329, the Medicaid Reentry Act H.R. 1839, the Medicaid Services Investment and Accountability Act of 2019 H.R. 3925, the Reducing Barriers to Substance Use Treatment Act

Client expense: $238,000 · Firm income: Not reported

Government targets: Bureau of Citizenship & Immigration Services (BCIS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of the Vice President of the United States, SENATE, Veterans Affairs, Dept of (VA), White House Office

H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act H.R. 133 - Consolidated Appropriations Act, 2021 no specific bills, Medicare Part D, Value based purchasing, Medicare Part B, 340B, Medicare coverage & reimbursement, insulin, Senate and Finance Drug bill, Medicaid Value Based Payment Rule and AMP Cap

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 7659 Re: ensuring parity for Audio Only Telehealth (Sewell) S. 3001 Toomey, regarding Medicare and Medicaid program extensions HR 4932, Thompson regarding telehealth in the Medicare program S. 2741 Schatz, regarding telehealth in the Medicare program HR 1839, the Medicaid Services Investment and Accountability Act HR 3253, The Empowering Beneficiaries, Ensuring Access and Strengthening Accountability Act (regarding Medicaid) HR 2131 and S. 1114, regarding the Medicare Advantage benchmark cap HR 3107, regarding the use of preauthorization in the Medicare Advantage program HR 3417 the Beneficiary Education Tools, Telehealth and Extenders Reauthorization Act (regarding Medicare) Legislation and regulation regarding the Medicare Advantage program HR 1839, regarding multiple Medicaid program changes, including the Medicaid Drug Rebate program. HR 1046 and S. 377, regarding Medicare Part D and requirements for HHS to negotiate drug prices HR 1781 Regarding MedPAC and MACPAC access to drug pricing and rebate data.

Client expense: $160,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicare and Medicaid reimbursement; Medicaid Services Investment and Accountability Act (H.R. 1839); surprise billing; prescription drug pricing; The End Surprise Billing Act of 2019 (H.R. 861); The Lower Healthcare Costs Act (S. 1895); The No Surprises Act (H.R. 3630); DSH payments; Medicaid Fiscal Accountability Regulation; Families First Coronavirus Response Act (H.R. 6201); Coronavirus Preparedness and Response Supplemental Appropriations Act 2020 (H.R. 6074); CARES Act (S. 3548/H.R. 748); telehealth coverage and reimbursement; The Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act (H.R. 6800); Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; FY 2021 Consolidated Appropriations Act (H.R. 133).

Client expense: Not reported · Firm income: $110,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

Medicaid access and coverage, Sunshine, medically complex children, access and affordability, transparency, Medicaid Value Based Payment rule H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act H.R. 133 - Consolidated Appropriations Act, 2021

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicaid Drug Rebate Program, coverage, state program operations, waivers, gene therapy, value based contracting, Medicaid Value Based Payment rule H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act H.R. 133 - Consolidated Appropriations Act, 2021

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

drug coverage and reimbursement, Medicaid, Medicare, Part B, Part D 6 protected classes, vial size, authorized generics, AMP CAP value based contracting, access and affordability H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act S. 3013 - Encouraging Innovative Benefit Design to Lower Costs for Seniors Act S. 3129 - Lower Costs, More Cures Act of 2019 H.R. 133 - Consolidated Appropriations Act, 2021

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Medicare priorities, coverage and payment policies, discount cards, MedPAC H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 133 - Consolidated Appropriations Act, 2021 no specific bill, Sunshine implementation, Part B, Medicare Part D, Smoking cessation, value based arrangements, drug pricing, benefit redesign

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act S. 3013 - Encouraging Innovative Benefit Design to Lower Costs for Seniors Act S. 3129 - Lower Costs, More Cures Act of 2019 H.R. 133 - Consolidated Appropriations Act, 2021 no specific bills, Medicare and Medicaid Drug Reimbursement, Medicaid Rebate, dual eligibles, Sunshine, discount cards, MedPAC, Alternative Payment Models, Value Based Purchasing, coding, CMMI, Part B, Part D, non-interference, prescription drug access and affordability, transparency, rebates, value based arrangements, benefit redesign, international reference pricing, Medicare drug cards, Medicaid Value Based Payment rule, Medicaid waivers

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 133 - Consolidated Appropriations Act, 2021 no specific bills, access to contraception, immunization access, MedPAC, icd-10, Part D, CMMI, Vaccines for Children Program, Coding, prescription drug access and affordability, value based arrangements, Medicaid, Medicare Part B, Medicare Part D, rebate cap, benefit design, patient out of pocket

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 133 - Consolidated Appropriations Act, 2021 no specific bill, program integrity, recovery audit, third party liability, pre-payment, verification, opioids, payfors, appeals, extenders

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 133 - Consolidated Appropriations Act, 2021 no specific bill, Medicare, Medicaid, Rate Notice and Call Letter, Medigap, Medicaid Program Operations, Medicare Operations, MLR, Money Follows the Person, sequestration

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Medicare and Medicaid Drug Reimbursement, Medicaid Rebate, Medicare Part D Non-Interference, health care reform, biosimilars, 340B, Sunshine, discount cards, MedPAC, coding, ASP, Part B, prescription drug access and affordability, transparency, international reference pricing, Stark & anti-kickback policies, home infusion, covid therapeutics and Medicare drug card H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 133 - Consolidated Appropriations Act, 2021

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

S. 2772, H.R. 884: Medicare Mental Health Access Act. H.R. 1301: The Mental Health Telemedicine Expansion Act H.R.1839: Medicaid Services Investment and Accountability Act of 2019 H.R. 1530, S. 595: Treat & Reduce Obesity H.R. 1329: Medicaid Reentry Act H.R. 3417: Beneficiary Education Tools Telehealth Extender Reauthorization Act of 2019 H.R. 5575: Primary Care and Behavioral Health Access Act H/S bill is under HCR S.3999: Mental and Behavioral Health Connectivity Act H.R. 6644, S. 3741: Health Care at Home Act H.R. 5201: Telemental Health Expansion Act H.R. 7663: Protecting Access to Post Covid-19 Telehealth Act H.R.4996: Helping MOMS Act of 2020 SF H.R.7539: Strengthening Behavioral Health Parity Act H.R. 9035: Permanency for Audio-Only Telehealth Act H,R, 8702, S. 5007: Holding Providers Harmless From Medicare Cuts During COVID-19 Act H.R. 8840: Medicare Sequester COVID Moratorium Act S. 4013, H.R. 7593: TREATS Act

Client expense: $216,000 · Firm income: Not reported

Government targets: Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Natl Science Foundation (NSF), SENATE

H.R. 107, Burgess: Rebate cap, regarding all bio-pharmaceutical related provisions. H.R. 275, Medicare Prescription Drug Negotiation Act, regarding all bio-pharmaceutical related provisions. H.R. 366, Insulin Access for All Act, regarding all bio-pharmaceutical related provisions. H.R. 1034, D. Collins/S. 640, Kennedy: Phair Pricing Act - Share the savings, regarding all bio-pharmaceutical related provisions. H.R. 1035, Prescription Drug Price Transparency Act, regarding all bio-pharmaceutical related provisions. H.R. 1332, Fair Care Act, regarding all bio-pharmaceutical related provisions. H.R. 1346, Medicare Buy-In and Health Care Stabilization Act, regarding all bio-pharmaceutical related provisions. H.R. 1384, Medicare for All Act, regarding all bio-pharmaceutical related provisions. H.R. 1781, Payment Commission Data Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 1788, Limits the penalty for Part B late enrollment to 15 percent and twice the period of no enrollment, regarding all bio-pharmaceutical related provisions. H.R. 2087, Reporting drug pricing information to Medicare, regarding all bio-pharmaceutical related provisions. H.R. 2113, Prescription STAR Act, regarding all bio-pharmaceutical related provisions. H.R.3, Lower Drug Costs Now Act of 2019, regarding all bio-pharmaceutical related provisions S. 62, Empowering Medicare Seniors to Negotiate Drug Prices, regarding all bio-pharmaceutical related provisions. S. 99, Medicare Drug Price Negotiation Act, regarding all bio-pharmaceutical related provisions. S. 205, Right Rebate Act, regarding all bio-pharmaceutical related provisions. S. 377/H.R. 1046, Medicare Negotiation and Competitive Licensing Act, regarding all bio-pharmaceutical related provisions. S. 470, Medicare at 50 Act, regarding all bio-pharmaceutical related provisions. S. 474, Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019 , regarding all bio-pharmaceutical related provisions. S. 475, RxCAP Act, regarding all bio-pharmaceutical related provisions. S. 476, Creating Transparency to Have Drug Rebates Unlocked (C-THRU Act) of 2019, regarding all bio-pharmaceutical related provisions. S. 551, REFUND Act of 2019, regarding all bio-pharmaceutical related provisions. S. 691, Expands Part D OOP assistance for low-income seniors and individuals with disabilities, regarding all bio-pharmaceutical related provisions. S. 801/H.R. 1781, Allows MedPAC and MACPAC to have access to information on drug rebates, regarding all bio-pharmaceutical related provisions. S. 981, Medicare-X Choice Act of 2019, regarding all bio-pharmaceutical related provisions. Pending rule to change the Rebate Safe Harbor, regarding all bio-pharmaceutical related provisions. H.R. 1839, Medicaid Services Investment and Accountability Act, regarding all bio-pharmaceutical related provisions H.R. 2452, Medicare for America Act, regarding all bio-pharmaceutical related provisions H.R. 3107, Improving Seniors Timely Access to Care Act, regarding all bio-pharmaceutical related provisions H.R. 3327, Drug Price Transparency for Medicare Patients Act, regarding all bio-pharmaceutical related provisions S. 1261/H.R. 2463, Choose Medicare Act, regarding all bio-pharmaceutical related provisions S. 1497, Health Care Price Check Act, regarding all bio-pharmaceutical related provisions S. 2081, a bill to require drug manufacturers to provide rebates for drugs furnished under Medicare Part B for which the growth in average sales price has exceeded inflation, regarding all bio-pharmaceutical related provisions. S. 2543, Prescription Drug Pricing Reduction Act of 2019, regarding all bio-pharmaceutical provisions. H.R. 19/S.3129 , Lower Costs, More Cures Act of 2019, regarding all bio-pharmaceutical related provisions H.R. 6218/S. 3457, Preserving Patient Access to Home Infusion Act, regarding all bio-pharmaceutical related provisions No Bill, Reimbursement for and patient access to Chimeric Antigen Receptor (CAR) T-cell therapies. Most Favored Nation (MFN) Model - (CMS-5528-IFC)

Client expense: $1,090,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, U.S. Trade Representative (USTR)

H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act H.R. 133 - Consolidated Appropriations Act, 2021 no specific bills, Medicare Part D, Value based purchasing, Medicare Part B, 340B, Medicare coverage & reimbursement, insulin, Senate and Finance Drug bill, Medicaid Value Based Payment Rule and AMP Cap

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 870 - Chronic Care H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 133 - Consolidated Appropriations Act, 2021 no specific bills, Medicare, Medicare Fraud, Medicare Advantage, Medicaid, Electronic Prescribing, Health Care Reform Implementation, Medigap reform, Physician Payment Reform, Delivery System Reform, medical review, Benefit design, Regional PPOs, chronic care, Medicare Advantage Payment Shift Offset, call letter, Puerto Rico and Medicare Advantage, ESRD, risk adjustment, opioids, interoperability, innovation center, privacy, cybersecurity, member identification

Client expense: Not reported · Firm income: $100,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 133 - Consolidated Appropriations Act, 2021 no specific bills, Medicare and Medicaid Drug Coverage and Reimbursement, Medicaid Rebate, Medicare Part D, Non-Interference, health care reform implementation, AMP, Sunshine, conditions of participation, care transitions, immunizations, pipeline, Innovation Center, Part B, Medicaid coverage, ESRD, coverage, innovative payments, diabetes and cardiometabolic health, vial size, AMP Cap, International reference pricing, Medicaid Value Based Payment Rule

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

PL 111-148 - The Patient Protection and Affordable Care Act, implementation H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 1226/S. 317 - ACE Kids Act of 2019 H.R. 133 - Consolidated Appropriations Act, 2021 no specific bills, Medicare and Medicaid Fraud, Advantage, Medicare Part D, Medicaid, Medicaid expansion, Electronic Prescribing, Dual Eligibles, Medigap reform, claims resolution, risk adjustment, Delivery System Reform, Special Needs Plans, Star Ratings, call letter, program integrity, Alzheimer's care, telehealth, chronic care, coding intensity, Medicaid per capita caps, block grant, long term services and supports, value based purchasing, Medicaid MLR, spread pricing, social determinants of health, mental health and substance abuse

Client expense: Not reported · Firm income: $90,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

IPPS, OPPS and other regulations impacting hospitals. P.L. 116-260/H.R. 133 - Consolidated Appropriations Act of 2021 - Issues related to the fight against COVID-19 including issues of vaccine distribution, testing policies and procedures and support of the nation's health care system, patients, families and their care providers. H.R. 8319 - Continuing Appropriation Act 2021 - Ensuring that "health extenders" are addressed. H.R. 8406 - The HEROES Act (modified) - Issues related to ensuring that hospitals are able to support patients with the full battery of services needed during the COVID-19 pandemic. Senate HEALS Act - Issues related to ensuring that hospitals are able to support patients with the full battery of services needed during the COVID-19 pandemic. H.R. 6800 - The HEROES Act - Issues related to support for patients, providers and hospitals fighting against COVID-19. H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriation Act of 2020- IMPLEMENTATION - Issues related to ensuring that not-for-profit hospitals, providers and hospital systems are able to best prevent, test, diagnose and treat the outbreak of COVID-19. H.R. 6201 - Families First Coronavirus Response Act - IMPLEMENTATION - Issues related to ensuring that not-for-profit hospitals, providers and hospital systems are able to best prevent, test, diagnose and treat the outbreak of COVID-19. H.R. 748 - The CARES Act - IMPLEMENTATION- Issues related to support not-for-profit hospitals to best respond to the COVID-19 pandemic. H.R. 5473 - EASE Behavioral Services Act - Issues related to increasing the use of telemedicine for behavioral health services in Medicare. H.R. 1839- The Medicaid Service,Investments and Accountability Act of 2019 - Policies related to caring for children with multiple complex conditions. H.R. 3417 - The Beneficiary Education Tools Telehealth Extender Reauthorization Act of 2019 - support for policies that allow for increased GME slots for underserved areas and increased utilization of telemedicine in Medicare. S. 1895 - Lower Health Costs Act of 2019 - Issues related to addressing the practice of surprise billing in private health care. Issues related to supporting the 340(b) program to ensure the best care possible for low income Americans. Issues related to increasing GME slots for hospitals in communities with growing populations. Issues related to the promotion of the Medicaid DSH program. Issues related to advancing behavioral health services for children and other underserved populations.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Advancing Care for Exceptional Kids Act of 2019 (ACE Kids Act) (S.317/H.R.1226) CARING for Kids Act (H.R. 6151) Covering life-saving investigations needed in cancer and other life-threatening conditions through timely use of resources for easy and affordable treatment for Medicaid enrollees in need today act (CLINICAL TREATMENTS ACT) (H.R.913) Increasing Access to Quality Cardiac Rehabilitation Care Act of 2019 (H.R. 3911/S.2842) Medicaid Services Investment & Accountability Act of 2019 (H.R.1839) Medicaid Waivers Provider scope of practice for cardiac and pulmonary rehabilitation

Client expense: $170,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office

HR1839; S.237/HR808; S.317/H.R.1226; S.433; HR748

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR1839; S.237/HR808; S.317/H.R.1226; S.433; HR748

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare and Medicaid reimbursement; Medicaid Services Investment and Accountability Act (H.R. 1839); surprise billing; prescription drug pricing; The End Surprise Billing Act of 2019 (H.R. 861); The Lower Healthcare Costs Act (S. 1895); The No Surprises Act (H.R. 3630); DSH payments; Medicaid Fiscal Accountability Regulation; Families First Coronavirus Response Act (H.R. 6201); Coronavirus Preparedness and Response Supplemental Appropriations Act 2020 (H.R. 6074); CARES Act (S. 3548/H.R. 748); telehealth coverage and reimbursement; The Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act (H.R. 6800); Health, Economic Assistance, Liability Protection and Schools (HEALS) Act.

Client expense: Not reported · Firm income: $110,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 no specific bills, access to contraception, immunization access, MedPAC, icd-10, Part D, CMMI, Vaccines for Children Program, Coding, prescription drug access and affordability, value based arrangements, Medicaid, Medicare Part B, Medicare Part D, rebate cap, benefit design, patient out of pocket

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

S. 2772, H.R. 884: Medicare Mental Health Access Act. H.R. 1301: The Mental Health Telemedicine Expansion Act H.R.1839: Medicaid Services Investment and Accountability Act of 2019 H.R. 1530, S. 595: Treat & Reduce Obesity H.R. 1329: Medicaid Reentry Act H.R. 3417: Beneficiary Education Tools Telehealth Extender Reauthorization Act of 2019 H.R. 5575: Primary Care and Behavioral Health Access Act S.3999 Mental and Behavioral Health Connectivity Act H.R. 6644/S3741 Health Care at Home Act H.R. 5201 Telemental Health Expansion Act H.R. Protecting Access to Post Covid-19 Telehealth Act

Client expense: $280,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Science Foundation (NSF), Natl Security Agency (NSA), SENATE, Veterans Affairs, Dept of (VA)

HR 7659 Re: ensuring parity for Audio Only Telehealth (Sewell) S. 3001 Toomey, regarding Medicare and Medicaid program extensions HR 4932, Thompson regarding telehealth in the Medicare program S. 2741 Schatz, regarding telehealth in the Medicare program HR 1839, the Medicaid Services Investment and Accountability Act HR 3253, The Empowering Beneficiaries, Ensuring Access and Strengthening Accountability Act (regarding Medicaid) HR 2131 and S. 1114, regarding the Medicare Advantage benchmark cap HR 3107, regarding the use of preauthorization in the Medicare Advantage program HR 3417 the Beneficiary Education Tools, Telehealth and Extenders Reauthorization Act (regarding Medicare) Legislation and regulation regarding the Medicare Advantage program HR 1839, regarding multiple Medicaid program changes, including the Medicaid Drug Rebate program. HR 1046 and S. 377, regarding Medicare Part D and requirements for HHS to negotiate drug prices HR 1781 Regarding MedPAC and MACPAC access to drug pricing and rebate data.

Client expense: $200,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 107, Burgess: Rebate cap, regarding all bio-pharmaceutical related provisions. H.R. 275, Medicare Prescription Drug Negotiation Act, regarding all bio-pharmaceutical related provisions. H.R. 366, Insulin Access for All Act, regarding all bio-pharmaceutical related provisions. H.R. 1034, D. Collins/S. 640, Kennedy: Phair Pricing Act - Share the savings, regarding all bio-pharmaceutical related provisions. H.R. 1035, Prescription Drug Price Transparency Act, regarding all bio-pharmaceutical related provisions. H.R. 1332, Fair Care Act, regarding all bio-pharmaceutical related provisions. H.R. 1346, Medicare Buy-In and Health Care Stabilization Act, regarding all bio-pharmaceutical related provisions. H.R. 1384, Medicare for All Act, regarding all bio-pharmaceutical related provisions. H.R. 1781, Payment Commission Data Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 1788, Limits the penalty for Part B late enrollment to 15 percent and twice the period of no enrollment, regarding all bio-pharmaceutical related provisions. H.R. 2087, Reporting drug pricing information to Medicare, regarding all bio-pharmaceutical related provisions. H.R. 2113, Prescription STAR Act, regarding all bio-pharmaceutical related provisions. H.R.3, Lower Drug Costs Now Act of 2019, regarding all bio-pharmaceutical related provisions S. 62, Empowering Medicare Seniors to Negotiate Drug Prices, regarding all bio-pharmaceutical related provisions. S. 99, Medicare Drug Price Negotiation Act, regarding all bio-pharmaceutical related provisions. S. 205, Right Rebate Act, regarding all bio-pharmaceutical related provisions. S. 377/H.R. 1046, Medicare Negotiation and Competitive Licensing Act, regarding all bio-pharmaceutical related provisions. S. 470, Medicare at 50 Act, regarding all bio-pharmaceutical related provisions. S. 474, Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019 , regarding all bio-pharmaceutical related provisions. S. 475, RxCAP Act, regarding all bio-pharmaceutical related provisions. S. 476, Creating Transparency to Have Drug Rebates Unlocked (C-THRU Act) of 2019, regarding all bio-pharmaceutical related provisions. S. 551, REFUND Act of 2019, regarding all bio-pharmaceutical related provisions. S. 691, Expands Part D OOP assistance for low-income seniors and individuals with disabilities, regarding all bio-pharmaceutical related provisions. S. 801/H.R. 1781, Allows MedPAC and MACPAC to have access to information on drug rebates, regarding all bio-pharmaceutical related provisions. S. 981, Medicare-X Choice Act of 2019, regarding all bio-pharmaceutical related provisions. Pending rule to change the Rebate Safe Harbor, regarding all bio-pharmaceutical related provisions. H.R. 1839, Medicaid Services Investment and Accountability Act, regarding all bio-pharmaceutical related provisions H.R. 2452, Medicare for America Act, regarding all bio-pharmaceutical related provisions H.R. 3107, Improving Seniors Timely Access to Care Act, regarding all bio-pharmaceutical related provisions H.R. 3327, Drug Price Transparency for Medicare Patients Act, regarding all bio-pharmaceutical related provisions S. 1261/H.R. 2463, Choose Medicare Act, regarding all bio-pharmaceutical related provisions S. 1497, Health Care Price Check Act, regarding all bio-pharmaceutical related provisions S. 2081, a bill to require drug manufacturers to provide rebates for drugs furnished under Medicare Part B for which the growth in average sales price has exceeded inflation, regarding all bio-pharmaceutical related provisions. S. 2543, Prescription Drug Pricing Reduction Act of 2019, regarding all bio-pharmaceutical provisions. H.R. 19/S.3129 , Lower Costs, More Cures Act of 2019, regarding all bio-pharmaceutical related provisions H.R. 6218/S. 3457, Preserving Patient Access to Home Infusion Act, regarding all bio-pharmaceutical related provisions No Bill, Reimbursement for and patient access to Chimeric Antigen Receptor (CAR) T-cell therapies.

Client expense: $1,600,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, U.S. Trade Representative (USTR)

Medicare priorities, coverage and payment policies, discount cards, MedPAC H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 no specific bill, Sunshine implementation, Part B, Medicare Part D, Smoking cessation, value based arrangements, drug pricing, benefit redesign

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 no specific bill, program integrity, recovery audit, third party liability, pre-payment, verification, opioids, payfors, appeals, extenders

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 no specific bill, Medicare, Medicaid, Rate Notice and Call Letter, Medigap, Medicaid Program Operations, Medicare Operations, MLR, Money Follows the Person

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act no specific bills, Medicare Part D, Value based purchasing, Medicare Part B, 340B, Medicare coverage & reimbursement, insulin, Senate and Finance Drug bill

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1329, the Medicaid Reentry Act H.R. 1839, the Medicaid Services Investment and Accountability Act of 2019 H.R. 3925, the Reducing Barriers to Substance Use Treatment Act

Client expense: $144,000 · Firm income: Not reported

Government targets: Bureau of Citizenship & Immigration Services (BCIS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of the Vice President of the United States, SENATE, Veterans Affairs, Dept of (VA), White House Office

Medicaid Drug Rebate Program, coverage, state program operations, waivers, gene therapy, value based contracting H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act S. 3013 - Encouraging Innovative Benefit Design to Lower Costs for Seniors Act S. 3129 - Lower Costs, More Cures Act of 2019 no specific bills, Medicare and Medicaid Drug Reimbursement, Medicaid Rebate, dual eligibles, Sunshine, discount cards, MedPAC, Alternative Payment Models, Value Based Purchasing, coding, CMMI, Part B, Part D, non-interference, prescription drug access and affordability, transparency, rebates, value based arrangements, benefit redesign, international reference pricing

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicaid access and coverage, Sunshine, medically complex children, access and affordability, transparency H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

IPPS, OPPS and other regulations impacting hospitals. H.R. 8319 - Continuing Appropriation Act 2021 - Ensuring that "health extenders" are addressed. H.R. 8406 - The HEROES Act (modified) - Issues related to ensuring that hospitals are able to support patients with the full battery of services needed during the COVID-19 pandemic. Senate HEALS Act - Issues related to ensuring that hospitals are able to support patients with the full battery of services needed during the COVID-19 pandemic. H.R. 6800 - The HEROES Act - Issues related to support for patients, providers and hospitals fighting against COVID-19. H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriation Act of 2020- IMPLEMENTATION - Issues related to ensuring that not-for-profit hospitals, providers and hospital systems are able to best prevent, test, diagnose and treat the outbreak of COVID-19. H.R. 6201 - Families First Coronavirus Response Act - IMPLEMENTATION - Issues related to ensuring that not-for-profit hospitals, providers and hospital systems are able to best prevent, test, diagnose and treat the outbreak of COVID-19. H.R. 748 - The CARES Act - IMPLEMENTATION- Issues related to support not-for-profit hospitals to best respond to the COVID-19 pandemic. H.R. 5473 - EASE Behavioral Services Act - Issues related to increasing the use of telemedicine for behavioral health services in Medicare. H.R. 1839- The Medicaid Service,Investments and Accountability Act of 2019 - Policies related to caring for children with multiple complex conditions. H.R. 3417 - The Beneficiary Education Tools Telehealth Extender Reauthorization Act of 2019 - support for policies that allow for increased GME slots for underserved areas and increased utilization of telemedicine in Medicare. S. 1895 - Lower Health Costs Act of 2019 - Issues related to addressing the practice of surprise billing in private health care. Issues related to supporting the 340(b) program to ensure the best care possible for low income Americans. Issues related to increasing GME slots for hospitals in communities with growing populations. Issues related to the promotion of the Medicaid DSH program. Issues related to advancing behavioral health services for children and other underserved populations.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

PL 111-148 - The Patient Protection and Affordable Care Act, implementation H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 1226/S. 317 - ACE Kids Act of 2019 no specific bills, Medicare and Medicaid Fraud, Advantage, Medicare Part D, Medicaid, Medicaid expansion, Electronic Prescribing, Dual Eligibles, Medigap reform, claims resolution, risk adjustment, Delivery System Reform, Special Needs Plans, Star Ratings, call letter, program integrity, Alzheimer's care, telehealth, chronic care, coding intensity, Medicaid per capita caps, block grant, long term services and supports, value based purchasing, Medicaid MLR, spread pricing, social determinants of health, mental health and substance abuse

Client expense: Not reported · Firm income: $90,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

S. 870 - Chronic Care H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 no specific bills, Medicare, Medicare Fraud, Medicare Advantage, Medicaid, Electronic Prescribing, Health Care Reform Implementation, Medigap reform, Physician Payment Reform, Delivery System Reform, medical review, Benefit design, Regional PPOs, chronic care, Medicare Advantage Payment Shift Offset, call letter, Puerto Rico and Medicare Advantage, ESRD, risk adjustment, opioids, interoperability, innovation center, privacy, cybersecurity, member identification

Client expense: Not reported · Firm income: $110,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Medicare and Medicaid Drug Reimbursement, Medicaid Rebate, Medicare Part D Non-Interference, health care reform, biosimilars, 340B, Sunshine, discount cards, MedPAC, coding, ASP, Part B, prescription drug access and affordability, transparency, international reference pricing, Stark & anti-kickback policies, home infusion H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 no specific bills, Medicare and Medicaid Drug Coverage and Reimbursement, Medicaid Rebate, Medicare Part D, Non-Interference, health care reform implementation, AMP, Sunshine, conditions of participation, care transitions, immunizations, pipeline, Innovation Center, Part B, Medicaid coverage, ESRD, coverage, innovative payments, diabetes and cardiometabolic health, vial size, AMP Cap, International reference pricing

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

drug coverage and reimbursement, Medicaid, Medicare, Part B, Part D 6 protected classes, vial size, authorized generics, AMP CAP value based contracting, access and affordability H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act S. 3013 - Encouraging Innovative Benefit Design to Lower Costs for Seniors Act S. 3129 - Lower Costs, More Cures Act of 2019

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE